Masitinib in Combination With Riluzole for the Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS)
Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
The objective is to compare the efficacy and safety of masitinib in combination with riluzole
in the treatment of patients suffering from Amyotrophic Lateral Sclerosis (ALS).